Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Rohto Pharmaceutical to Offer Three Regenerative Drugs by 2020

Filed Under: Innovation, Pharma, Products Tagged With: , ,

Rohto Pharmaceutical Co. Ltd. (TYO:4527) plans to put three new regenerative medical drugs on the market by 2020, using a…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

LSII to Launch Clinical Trials of Muse Cells to Treat Respiratory Failure in COVID-19 Patients
LSII to Launch Clinical Trials of Muse Cells to Treat…
Teijin Expands Health Care Operations for Bone and Joint Diseases
Teijin Expands Health Care Operations for Bone and Joint…
Keio University Venture Looks to Achieve Breakthrough in Cardiovascular Regenerative Medicine
Keio University Venture Looks to Achieve Breakthrough in…
Mitsubishi Chemical to Produce Regenerative Medicine Materials From Plants
Mitsubishi Chemical to Produce Regenerative Medicine…
Sumitomo Dainippon Pharma to Expand Regenerative and Cellular Medicine CDMO Operations
Sumitomo Dainippon Pharma to Expand Regenerative and…
Sekisui Chemical to Build New Biopharmaceutical Plant in UK
Sekisui Chemical to Build New Biopharmaceutical Plant in UK